About Indo Spectrum Pharmaceuticals
Indo Spectrum Pharmaceuticals is a company. The company has 40 employees as of April 08, 2024. Indo Spectrum Pharmaceuticals offers products and services including Docosa and Spectrofer Tablet.
- Employees 40 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Indo Spectrum Pharmaceuticals Private Limited
- Jurisdiction Mysore, Karnataka, India
-
Annual Revenue
$931.04 K (USD)-2.59as on Mar 31, 2020
-
Net Profit
$98.23 K (USD)5.72as on Mar 31, 2020
-
EBITDA
$300.21 K (USD)147.14as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
40
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indo Spectrum Pharmaceuticals
Indo Spectrum Pharmaceuticals offers a comprehensive portfolio of products and services, including Docosa and Spectrofer Tablet.
Docosa is provided as a therapeutic solution in the company's lineup of formulations.
Spectrofer Tablet is offered as part of the company's range of innovative pharmaceutical products.
Funding Insights of Indo Spectrum Pharmaceuticals
Detailed funding history for Indo Spectrum Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indo Spectrum Pharmaceuticals
Investment portfolio details for Indo Spectrum Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indo Spectrum Pharmaceuticals
Detailed financials for Indo Spectrum Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indo Spectrum Pharmaceuticals Comparisons
Peer comparison for Indo Spectrum Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indo Spectrum Pharmaceuticals
Detailed competitors of Indo Spectrum Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indo Spectrum Pharmaceuticals
Complete news archive for Indo Spectrum Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indo Spectrum Pharmaceuticals
As of Apr 08, 2024, the latest employee count at Indo Spectrum Pharmaceuticals is 40.
Annual revenue of Indo Spectrum Pharmaceuticals is $931.04K as on Mar 31, 2020.
Indo Spectrum Pharmaceuticals was founded as a firm in Karnataka on October 21, 2007, and was incorporated in 2009 to deliver quality innovative therapeutic solutions. The companys operations are guided by the principle of Bring Colours to Life, which is used to inform all actions and maintain trust among the medical fraternity. Various specialities such as Gynaecology, Cardiology, and Diabetology are served, with a focus on exceeding customer expectations and prioritizing patient interests. Ethical practices and sustained growth are emphasized, along with introductions of first-time products in India. The company is positioned within the dynamic pharmaceutical industry through its marketing innovations and committed sales efforts.
Indo Spectrum Pharmaceuticals offers Docosa and Spectrofer Tablet.